Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Intas will have development and commercialization rights to the drug for several indications including ES-SCLC and for a specific formulation of the drug.